NewAmsterdam Pharma Company
NAMS
#4245
Rank
โ‚ฌ1.93 B
Marketcap
20,99ย โ‚ฌ
Share price
3.95%
Change (1 day)
120.15%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2024 (TTM): -โ‚ฌ0.17 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are โ‚ฌ14.02 Million. In 2022 the company made an earning of -โ‚ฌ22.64 Million, an increase over its 2021 earnings that were of -โ‚ฌ41.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ0.17 Billion
2022-โ‚ฌ22.64 Million-45.83%
2021-โ‚ฌ41.79 Million490.94%
2020-โ‚ฌ7.08 Million